These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1834011)

  • 1. In vitro and in vivo potentiation of chloroquine against malaria parasites by an enantiomer of amlodipine.
    Deloron P; Basco LK; Dubois B; Gaudin C; Clavier F; Le Bras J; Verdier F
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1338-42. PubMed ID: 1834011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum: in vitro drug interaction between chloroquine and enantiomers of amlodipine.
    Basco LK; Le Bras J
    Exp Parasitol; 1991 Apr; 72(3):262-70. PubMed ID: 1826656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo chloroquine-potentiating action of Strychnos myrtoides alkaloids against chloroquine-resistant strains of Plasmodium malaria.
    Rasoanaivo P; Ratsimamanga-Urverg S; Milijaona R; Rafatro H; Rakoto-Ratsimamanga A; Galeffi C; Nicoletti M
    Planta Med; 1994 Feb; 60(1):13-6. PubMed ID: 8134408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine.
    Pereira MR; Henrich PP; Sidhu AB; Johnson D; Hardink J; Van Deusen J; Lin J; Gore K; O'Brien C; Wele M; Djimde A; Chandra R; Fidock DA
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3115-24. PubMed ID: 21464242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloroquine-potentiating action of antihistaminics in Plasmodium falciparum in vitro.
    Basco LK; Ringwald P; Le Bras J
    Ann Trop Med Parasitol; 1991 Apr; 85(2):223-8. PubMed ID: 1686703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isradipine--a calcium channel blocker--does not potentiate chloroquine antiplasmodial activity against Plasmodium falciparum.
    Randrianarivelojosia M; Jambou R
    Parasite; 2005 Jun; 12(2):187-9. PubMed ID: 15991834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of drug susceptibility in Plasmodium falciparum in vitro and Plasmodium berghei in vivo by mixed-function oxidase inhibitors.
    Ndifor AM; Howells RE; Bray PG; Ngu JL; Ward SA
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1318-23. PubMed ID: 8328780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal activity of the naturally occurring chemosensitizer malagashanine in Plasmodium malaria.
    Rafatro H; Ramanitrahasimbola D; Rasoanaivo P; Ratsimamanga-Urverg S; Rakoto-Ratsimamanga A; Frappier F
    Biochem Pharmacol; 2000 May; 59(9):1053-61. PubMed ID: 10704934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of chloroquine in combination with chlorpromazine or prochlorperazine against isolates of Plasmodium falciparum.
    Basco LK; Le Bras J
    Antimicrob Agents Chemother; 1992 Jan; 36(1):209-13. PubMed ID: 1590691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of artesunate combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro.
    Fivelman QL; Walden JC; Smith PJ; Folb PI; Barnes KI
    Trans R Soc Trop Med Hyg; 1999; 93(4):429-32. PubMed ID: 10674097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of chloroquine resistance in falciparum malaria by some calcium channel inhibitors and optical isomers is independent of calcium channel blockade.
    Ye Z; Van Dyke K
    Drug Chem Toxicol; 1994; 17(2):149-62. PubMed ID: 8062642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum.
    Ridley RG; Hofheinz W; Matile H; Jaquet C; Dorn A; Masciadri R; Jolidon S; Richter WF; Guenzi A; Girometta MA; Urwyler H; Huber W; Thaithong S; Peters W
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1846-54. PubMed ID: 8843292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine.
    Oduola AM; Sowunmi A; Milhous WK; Brewer TG; Kyle DE; Gerena L; Rossan RN; Salako LA; Schuster BG
    Am J Trop Med Hyg; 1998 May; 58(5):625-9. PubMed ID: 9598452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive effects of ciprofloxacin on the in-vitro activity of chloroquine against a clinical isolate of Plasmodium falciparum.
    Kazzim OJ; Adegbolagun OM; Osho O; Anumudu CI
    Ann Trop Med Parasitol; 2006 Oct; 100(7):579-84. PubMed ID: 16989683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy between two calcium channel blockers, verapamil and fantofarone (SR33557), in reversing chloroquine resistance in Plasmodium falciparum.
    Adovelande J; Delèze J; Schrével J
    Biochem Pharmacol; 1998 Feb; 55(4):433-40. PubMed ID: 9514077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.
    Sashidhara KV; Avula SR; Palnati GR; Singh SV; Srivastava K; Puri SK; Saxena JK
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5455-9. PubMed ID: 22850213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of Plasmodium falciparum malaria to amodiaquine, chloroquine and quinine in the Madang Province of Papua New Guinea, 1990-1993.
    al-Yaman F; Genton B; Mokela D; Narara A; Raiko A; Alpers MP
    P N G Med J; 1996 Mar; 39(1):16-22. PubMed ID: 9522846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection.
    Chen M; Theander TG; Christensen SB; Hviid L; Zhai L; Kharazmi A
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1470-5. PubMed ID: 7979274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
    Nakornchai S; Konthiang P
    Parasitol Int; 2006 Sep; 55(3):195-9. PubMed ID: 16750932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.